{Reference Type}: Journal Article
{Title}: Family medicine journals' endorsement of reporting guidelines and clinical trial registration: a cross-sectional analysis.
{Author}: Compton W;Dennis B;Clark P;Smith CA;Nees D;Hughes G;Vassar M;
{Journal}: BJGP Open
{Volume}: 0
{Issue}: 0
{Year}: 2024 May 28
暂无{DOI}: 10.3399/BJGPO.2023.0183
{Abstract}: <B>BACKGROUND: </B>Family medicine, vital for patient care but underfunded, prompts an evaluation of how family medicine journals endorse, require, and advocate for reporting guidelines (RGs), clinical trial, and systematic review registration.<BR><B>OBJECTIVE: </B>Assess endorsement and requirement of RGs, and the stance on clinical trial and systematic review registration in family medicine journals, impacting research quality and transparency.<BR><B>METHODS: </B>A cross-sectional analysis of 43 "Family Practice" journals, identified through the 2021 Scopus CiteScore. Editors-in-Chief were contacted to confirm article types. Data extracted from "instructions to authors" pages focused on RG recommendations, requirements, and trial registration.<BR><B>METHODS: </B>To ensure confidentiality and prevent bias, authors independently extracted data on RG utilisation, adherence, and clinical trial registration provide a overview of research standards.<BR><B>RESULTS: </B>Of 43 journals, the most recommended guidelines were CONSORT (69%), PRISMA (58%), and STROBE (60%). The most required were PRISMA (16%) and CONSORT (11%). Clinical trial registration was recommended or required by 67% of journals. Additionally, 40 out of the 43 (93%) journals cited at least one reporting guideline in their instructions to authors.<BR><B>CONCLUSIONS: </B>Family medicine journals exhibit varied endorsement and requirement patterns for RGs and clinical trial registration. While guidelines like CONSORT, PRISMA, and STROBE are acknowledged, caution is needed in presuming a direct link to enhanced research quality. A nuanced approach, promoting diverse reporting guidelines and rigorous study registration, is essential for elevating transparency and advancing research standards in family medicine.